Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis
PLOS ONE · 20.02.2025 · 20 (2) · e0314825
DOI: 10.1371/journal.pone.0314825 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, online erschienen am 20.02.2025. Verfasst von Cong Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Endoscopic Ultrasound-Guided Fine Needle Aspiration, Pancreatic Cyst, Pancreatic Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Preoperative diagnosis of malignancy in patients with pancreatic cystic lesions (PCLs) remains challenging. The aim of this study was to assess the sensitivity, specificity, and positive and negative likelihood ratios (LRs) of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA)-based cytology in differentiating malignant PCLs from benign PCLs.
Methods
A comprehensive search was performed in multiple databases in November 2023. Studies differentiating benign and malignant PCLs via EUS-FNA-based cytology, in which the results were compared with those of surgical excision histopathology, were included in this meta-analysis. Data from the selected studies were pooled to summarize the sensitivity, specificity, positive and negative LRs, diagnostic odds ratios and summary receiver operating characteristic (SROC) curves.
Results
We included 755 patients from 15 distinct studies who underwent EUS-FNA-based cytology and had a histopathological diagnosis. The pooled sensitivity and specificity in diagnosing malignant PCLs were 0.62 (95% CI, 0.42–0.78) and 0.96 (95% CI, 0.91–0.98), respectively. The positive and negative LRs for diagnosing malignant PCLs were 16.3 (95% CI, 7.2–37.0) and 0.40 (95% CI, 0.25–0.64), respectively. The area under the curve (AUC) was 0.94 (95% CI, 0.91–0.95).
Conclusions
EUS-FNA-based cytology has overall high specificity, medium sensitivity and good diagnostic accuracy in differentiating malignant from benign PCLs. Further research is needed to improve the overall sensitivity of EUS-FNA-based cytology for the diagnosis of malignant PCLs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
- Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang, China.
- Hangzhou Institute of Digestive Diseases, Hangzhou, Zhejiang, China.
- Zhejiang Provincial Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research, Hangzhou, Zhejiang Province, China.
ORCID-Profile: Xiao-Feng Zhang
Zitieren
APA
Ding, C., Yang, J. F., Wang, X., Zhou, Y. F., Gu, Y., Liu, Q., Shen, H. Z., & Zhang, X. F. (2025). Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis. PLOS ONE, 20(2), e0314825. https://doi.org/10.1371/journal.pone.0314825
Vancouver
Ding C, Yang JF, Wang X, Zhou YF, Gu Y, Liu Q, et al. Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis. PLOS ONE. 2025;20(2):e0314825. doi:10.1371/journal.pone.0314825
BibTeX
@article{Ding2025,
author = {Ding, Cong and Yang, Jian-Feng and Wang, Xia and Zhou, Yi-Feng and Gu, Ye and Liu, Qiang and Shen, Hong-Zhang and Zhang, Xiao-Feng},
title = {Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {2},
pages = {e0314825},
doi = {10.1371/journal.pone.0314825}
}
EUVIMED